306 related articles for article (PubMed ID: 28250129)
1. Interferon Gamma Prevents Infectious Entry of Human Papillomavirus 16 via an L2-Dependent Mechanism.
Day PM; Thompson CD; Lowy DR; Schiller JT
J Virol; 2017 May; 91(10):. PubMed ID: 28250129
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of Human Papillomavirus Type 16 L2 Contributes to Efficient Virus Infectious Entry.
Broniarczyk J; Massimi P; Pim D; Bergant Marušič M; Myers MP; Garcea RL; Banks L
J Virol; 2019 Jul; 93(13):. PubMed ID: 30996086
[TBL] [Abstract][Full Text] [Related]
3. Topography of the Human Papillomavirus Minor Capsid Protein L2 during Vesicular Trafficking of Infectious Entry.
DiGiuseppe S; Keiffer TR; Bienkowska-Haba M; Luszczek W; Guion LG; Müller M; Sapp M
J Virol; 2015 Oct; 89(20):10442-52. PubMed ID: 26246568
[TBL] [Abstract][Full Text] [Related]
4. Vesicular trafficking of incoming human papillomavirus 16 to the Golgi apparatus and endoplasmic reticulum requires γ-secretase activity.
Zhang W; Kazakov T; Popa A; DiMaio D
mBio; 2014 Sep; 5(5):e01777-14. PubMed ID: 25227470
[TBL] [Abstract][Full Text] [Related]
5. Kallikrein-8 Proteolytically Processes Human Papillomaviruses in the Extracellular Space To Facilitate Entry into Host Cells.
Cerqueira C; Samperio Ventayol P; Vogeley C; Schelhaas M
J Virol; 2015 Jul; 89(14):7038-52. PubMed ID: 25926655
[TBL] [Abstract][Full Text] [Related]
6. Cleavage of the HPV16 Minor Capsid Protein L2 during Virion Morphogenesis Ablates the Requirement for Cellular Furin during De Novo Infection.
Cruz L; Biryukov J; Conway MJ; Meyers C
Viruses; 2015 Nov; 7(11):5813-30. PubMed ID: 26569287
[TBL] [Abstract][Full Text] [Related]
7. Alpha-defensin HD5 inhibits furin cleavage of human papillomavirus 16 L2 to block infection.
Wiens ME; Smith JG
J Virol; 2015 Mar; 89(5):2866-74. PubMed ID: 25540379
[TBL] [Abstract][Full Text] [Related]
8. The Cytoskeletal Adaptor Obscurin-Like 1 Interacts with the Human Papillomavirus 16 (HPV16) Capsid Protein L2 and Is Required for HPV16 Endocytosis.
Wüstenhagen E; Hampe L; Boukhallouk F; Schneider MA; Spoden GA; Negwer I; Koynov K; Kast WM; Florin L
J Virol; 2016 Dec; 90(23):10629-10641. PubMed ID: 27654294
[TBL] [Abstract][Full Text] [Related]
9. Cyclophilins facilitate dissociation of the human papillomavirus type 16 capsid protein L1 from the L2/DNA complex following virus entry.
Bienkowska-Haba M; Williams C; Kim SM; Garcea RL; Sapp M
J Virol; 2012 Sep; 86(18):9875-87. PubMed ID: 22761365
[TBL] [Abstract][Full Text] [Related]
10. Human Papillomavirus 16 Capsids Mediate Nuclear Entry during Infection.
Day PM; Weisberg AS; Thompson CD; Hughes MM; Pang YY; Lowy DR; Schiller JT
J Virol; 2019 Aug; 93(15):. PubMed ID: 31092566
[TBL] [Abstract][Full Text] [Related]
11. Efficient Inhibition of Human Papillomavirus Infection by L2 Minor Capsid-Derived Lipopeptide.
Yan H; Foo SS; Chen W; Yoo JS; Shin WJ; Wu C; Jung JU
mBio; 2019 Aug; 10(4):. PubMed ID: 31387913
[TBL] [Abstract][Full Text] [Related]
12. The nuclear retention signal of HPV16 L2 protein is essential for incoming viral genome to transverse the trans-Golgi network.
DiGiuseppe S; Bienkowska-Haba M; Hilbig L; Sapp M
Virology; 2014 Jun; 458-459():93-105. PubMed ID: 24928042
[TBL] [Abstract][Full Text] [Related]
13. A Novel PDZ Domain Interaction Mediates the Binding between Human Papillomavirus 16 L2 and Sorting Nexin 27 and Modulates Virion Trafficking.
Pim D; Broniarczyk J; Bergant M; Playford MP; Banks L
J Virol; 2015 Oct; 89(20):10145-55. PubMed ID: 26202251
[TBL] [Abstract][Full Text] [Related]
14. Identification of a role for the trans-Golgi network in human papillomavirus 16 pseudovirus infection.
Day PM; Thompson CD; Schowalter RM; Lowy DR; Schiller JT
J Virol; 2013 Apr; 87(7):3862-70. PubMed ID: 23345514
[TBL] [Abstract][Full Text] [Related]
15. Cell-penetrating peptide inhibits retromer-mediated human papillomavirus trafficking during virus entry.
Zhang P; Moreno R; Lambert PF; DiMaio D
Proc Natl Acad Sci U S A; 2020 Mar; 117(11):6121-6128. PubMed ID: 32123072
[TBL] [Abstract][Full Text] [Related]
16. L2, the minor capsid protein of papillomavirus.
Wang JW; Roden RB
Virology; 2013 Oct; 445(1-2):175-86. PubMed ID: 23689062
[TBL] [Abstract][Full Text] [Related]
17. A Cell-Free Assembly System for Generating Infectious Human Papillomavirus 16 Capsids Implicates a Size Discrimination Mechanism for Preferential Viral Genome Packaging.
Cerqueira C; Pang YY; Day PM; Thompson CD; Buck CB; Lowy DR; Schiller JT
J Virol; 2016 Jan; 90(2):1096-107. PubMed ID: 26559838
[TBL] [Abstract][Full Text] [Related]
18. The cellular endosomal protein stannin inhibits intracellular trafficking of human papillomavirus during virus entry.
Lipovsky A; Erden A; Kanaya E; Zhang W; Crite M; Bradfield C; MacMicking J; DiMaio D; Schoggins JW; Iwasaki A
J Gen Virol; 2017 Nov; 98(11):2821-2836. PubMed ID: 29058661
[TBL] [Abstract][Full Text] [Related]
19. Translocation of the papillomavirus L2/vDNA complex across the limiting membrane requires the onset of mitosis.
Calton CM; Bronnimann MP; Manson AR; Li S; Chapman JA; Suarez-Berumen M; Williamson TR; Molugu SK; Bernal RA; Campos SK
PLoS Pathog; 2017 May; 13(5):e1006200. PubMed ID: 28463988
[TBL] [Abstract][Full Text] [Related]
20. Direct binding of retromer to human papillomavirus type 16 minor capsid protein L2 mediates endosome exit during viral infection.
Popa A; Zhang W; Harrison MS; Goodner K; Kazakov T; Goodwin EC; Lipovsky A; Burd CG; DiMaio D
PLoS Pathog; 2015 Feb; 11(2):e1004699. PubMed ID: 25693203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
